BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37859330)

  • 1. miRNA as an Ultimate and Emerging Diagnostic Approach for the Detection of Alzheimer's Disease.
    Jain M; Agarwal S; Rana A; Tiwari A; Patil N
    Microrna; 2023; 12(3):189-204. PubMed ID: 37859330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease: presence and role of microRNAs.
    Basavaraju M; de Lencastre A
    Biomol Concepts; 2016 Aug; 7(4):241-52. PubMed ID: 27505094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease.
    Van Giau V; An SS
    J Neurol Sci; 2016 Jan; 360():141-52. PubMed ID: 26723991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNAs as Early Biomarkers of Alzheimer's Disease: A Synaptic Perspective.
    Siedlecki-Wullich D; Miñano-Molina AJ; Rodríguez-Álvarez J
    Cells; 2021 Jan; 10(1):. PubMed ID: 33435363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs as Therapeutic Tools in Alzheimer's Disease.
    Lee CY; Ryu IS; Ryu JH; Cho HJ
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets.
    Liu S; Fan M; Zheng Q; Hao S; Yang L; Xia Q; Qi C; Ge J
    Biomed Pharmacother; 2022 Apr; 148():112681. PubMed ID: 35177290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review of miRNA as Biomarkers in Alzheimer's Disease.
    Swarbrick S; Wragg N; Ghosh S; Stolzing A
    Mol Neurobiol; 2019 Sep; 56(9):6156-6167. PubMed ID: 30734227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of miRNAs in Alzheimer's Disease and Possible Fields of Application.
    Silvestro S; Bramanti P; Mazzon E
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31443326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer's disease.
    Abdelmaksoud NM; Sallam AM; Abulsoud AI; El-Dakroury WA; Abdel Mageed SS; Al-Noshokaty TM; Elrebehy MA; Elshaer SS; Mahmoud NA; Fathi D; Rizk NI; Elballal MS; Mohammed OA; Abdel-Reheim MA; Zaki MB; Saber S; Doghish AS
    Pathol Res Pract; 2024 Jan; 253():155007. PubMed ID: 38061270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities.
    Abuelezz NZ; Nasr FE; AbdulKader MA; Bassiouny AR; Zaky A
    Front Aging Neurosci; 2021; 13():743573. PubMed ID: 34712129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.
    Pan Y; Liu R; Terpstra E; Wang Y; Qiao F; Wang J; Tong Y; Pan B
    J Alzheimers Dis; 2016; 49(1):1-12. PubMed ID: 26484912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs Modulate the Pathogenesis of Alzheimer's Disease: An In Silico Analysis in the Human Brain.
    Gugliandolo A; Chiricosta L; Boccardi V; Mecocci P; Bramanti P; Mazzon E
    Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32846925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-generation biomarker discovery in Alzheimer's disease using metabolomics - from animal to human studies.
    Hurtado MO; Kohler I; de Lange EC
    Bioanalysis; 2018 Sep; 10(18):1525-1546. PubMed ID: 30198770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model.
    Chum PP; Hakim MA; Behringer EJ
    J Alzheimers Dis; 2022; 85(1):91-113. PubMed ID: 34776451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying Alzheimer's Disease-related miRNA Based on Semi-clustering.
    Zhao T; Wang D; Hu Y; Zhang N; Zang T; Wang Y
    Curr Gene Ther; 2019; 19(4):216-223. PubMed ID: 31549953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA Dysregulation in Alzheimer's Disease.
    Putteeraj M; Fairuz YM; Teoh SL
    CNS Neurol Disord Drug Targets; 2017; 16(9):1000-1009. PubMed ID: 28782488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
    Kumar S; Reddy PH
    Biochim Biophys Acta; 2016 Sep; 1862(9):1617-27. PubMed ID: 27264337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNAs in cerebrospinal fluid associated with Alzheimer's disease: A systematic review and pathway analysis using a data mining and machine learning approach.
    Pereira JD; Teixeira LCR; Mamede I; Alves MT; Caramelli P; Luizon MR; Veloso AA; Gomes KB
    J Neurochem; 2024 Jun; 168(6):977-994. PubMed ID: 38390627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease.
    Geekiyanage H; Jicha GA; Nelson PT; Chan C
    Exp Neurol; 2012 Jun; 235(2):491-6. PubMed ID: 22155483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discerning the Prospects of miRNAs as a Multi-Target Therapeutic and Diagnostic for Alzheimer's Disease.
    Bhatnagar D; Ladhe S; Kumar D
    Mol Neurobiol; 2023 Oct; 60(10):5954-5974. PubMed ID: 37386272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.